Table 1.
CD4 count and viral load results of client A (CA)
| Dates | CD4 count (cells/mm3) | Dates | Viral load (copies/ml) |
|---|---|---|---|
| 05/11/2013 | 10 | 19/11/2015 | 2,345 switched to the second line |
| 11/02/2014 | 60 | 08/07/2017 | 1,445 |
| 30/07/2015 | 67 | 02/08/2018 | 872 |
| 19/11/2015 | 115 | 27/06/2019 | 903 |
| 10/03/2016 | 150 | 27/06/2020 | 6,350 |
| 21/07/2016 | 244 | 10/06/2021 | 1,889 transitioned to TLD |
| 08/07/2017 | 395 | 08/09/2021 | <20 |
| 01/11/2021 | <20 | ||
| 25/07//2022 | <20 |
The data shows the CD4 count results and viral loads of client A at the initiation of ART and at the time of switch and transition; CD4: T-cell (white blood cells that fight infection); TLD: Tenofovir Lamivudine Dolutegravir antiretroviral therapy combination